Search Results 2031-2040 of 18779 for Relapse

  1. Clinical trials - Oncology (Medical)

    ... relapse, and subsequent therapy. Turkey Tail Mushrooms for women with ER+/HER2- Breast Cancer. Scottsdale/Phoenix, Ariz. The purpose of this study is to ...

  2. Breast radiotherapy team at Mayo Clinic adopts shortened courses to spare normal tissue

    ... relapse with standard therapy; A clinical trial investigating adjuvant poly-(ADP-ribose) polymerase inhibition with radiotherapy in inflammatory breast ...

  3. Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation (ReSPECT) - Mayo Clinic

    Diagnosis of chemotherapy-resistant lymphoma: a first relapse can occur provided that a second complete remission has occurred. 3. Suspected or diagnosed ...

  4. Clinical trials - Oncology (Medical)

    ... relapsed NSCLC. Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma. Rochester, Minn ...

  5. Individualized Medicine - 2025 Archives

    Mayo Clinic researchers link CAR-T cell aging to cancer relapse featured image. Mayo Clinic researchers link CAR-T cell aging to cancer relapse. Susan Murphy.

  6. A Phase 3, randomized, open-label, controlled study comparing the efficacy and safety of zanidatamab to trastuzumab, each in combination with physician’s choice chemotherapy, for the treatment of participants with metastatic HER2-positive breast cancer - Mayo Clinic

    Prior HER2-targeted neo-adjuvant or adjuvant therapy that resulted in relapse within 6 months of the completion of therapy will be considered a line of ...

  7. Ocrelizumab (intravenous route) - Side effects & uses - Mayo Clinic

    This medicine will not cure MS, but it may slow some of the disabling effects and decrease the number of relapses of the disease. This medicine is to be ...

  8. A Study of Copanlisib and Nivolumab in Treating Participants With Recurrent or Refractory Diffuse Large B-cell Lymphoma or Primary Mediastinal Large B-cell Lymphoma - Mayo Clinic

    Likely to have near normal lifespan if not for the presence of relapsed/refractory lymphoma. The Patients with evidence of HBV are eligible provided there ...

  9. E6201 Plus Dabrafenib for the Treatment of Metastatic Melanoma Central Nervous System Metastases (CNS) - Mayo Clinic

    ... relapsed or progressed from initial or systemic disease. . Participation eligibility. Participant eligibility includes age, gender, type and stage of disease ...

  10. Hematology - Clinical trials

    The purpose of this study is to assess the safety and tolerability of escalating intratumoral doses of mRNA-2752 in participants with relapsed/refractory solid ...